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Cytolethal distending toxins (CDT) are potent cytotoxins of several Gram-negative pathogenic bacteria, including Escherichia coli, in
which five types (CDT-I to CDT-V) have been identified so far. CDT-V is frequently associatedwith Shiga-toxigenic E. coli (STEC),
enterohemorrhagic E. coli (EHEC)O157 strains, and strains not fitting any established pathotypes. In this study, wewere the first to
sequence and annotate a 31.2-kb-long, noninducible P2-like prophage carrying the cdt-V operon from an stx- and eae-negative E. coli
O157:H43 strain of bovine origin. The cdt-V operon is integrated in the place of the tin and oldphage immunity genes (termed theTO
region) of the prophage, and the prophage itself is integrated into the bacterial chromosomebetween the housekeeping genes cpxP and
fieF. The presence of P2-like genes (n 20)was investigated in a further fiveCDT-V-positive bovine E. coliO157 strains of various
serotypes, three EHECO157:NMstrains, four strains expressing other variants of CDT, and eightCDT-negative strains. All but one
CDT-V-positive atypicalO157 strain uniformly carried all the investigated genomic regions of P2-like phages, while the EHECO157
strainsmissed three regions and theCDT-V-negative strains carried only a fewP2-like sequences.Our results suggest that P2-like
phages play a role in the dissemination of cdt-V between E. coliO157 strains and that after integration into the bacterial chromosome,
they adapted to the respective hosts and became temperate.
Cytolethal distending toxins (CDT) are considered prototypicinhibitory cyclomodulins (1, 2). Genes encoding CDTs are
widely disseminated among Gram-negative pathogenic bacteria,
including Escherichia coli, Campylobacter spp., Aggregatibacter ac-
tinomycetemcomitans, Haemophilus ducreyi, Salmonella enterica
serovar Typhimurium, and Shigella spp. (3).
The holotoxin is a heterotrimer of three protein subunits,
CdtA, CdtB, and CdtC. These are encoded by three adjacent,
sometimes slightly overlapping genes (4). CdtB is the active sub-
unit, possessing DNase activity and sharing homology with the
mammalian DNase I (5). There is evidence that in case of Campy-
lobacter spp., A. actinomycetemcomitans, andH. ducreyi, the other
two subunits play a role in the transport of CdtB into the target cell
(3). Upon entering the eukaryotic cell, CdtB causes DNA damage,
which in turn causes cell cycle arrest between the G2 andMphases
(6). Double-stranded DNA damage leads to the distension and
subsequent death of the target cell (7). The characteristic distend-
ing transformation has been demonstrated on multiple cell lines
by several studies (7, 8).
CDT was first identified in E. coli (Johnson and Lior) (9), and
its production has been associated with several pathotypes, e.g.,
enterohemorrhagic (EHEC) and enteropathogenic (EPEC) (3).
So far, five types have been associated with E. coli, termed CDT-I
to CDT-V (4, 6, 10, 11, 12). The genomic localization of cdt alleles
and their association with mobile genetic elements was reported
by several groups. Accordingly, Pérès et al. localized cdt-III to a
large conjugative virulence plasmid (6). cdt-I and cdt-IV are en-
coded by lambdoid prophages (13, 14), while the cdt-V operon is
flanked by P2-like phage sequences (11, 14, 15, 16), but the corre-
sponding nucleotide sequences deposited show only small por-
tions of the phage genes repA (replication gene A) andQ (a capsid
gene).
The presence of CDT-V in Shiga-toxigenic E. coli (STEC)
strains of various serotypes, both of clinical (17, 18) and nonclini-
cal (19) origin, has been reported. CDT-Vhas also been associated
with strains of other serotypes and pathotypes associated with
human diarrhea (16, 20), where it is the only known cytotoxin of
the respective strains, underlining the importance of CDT-V as a
virulence factor. Therefore, it is imperative to obtain more infor-
mation on the potential mobility of the CDT-V-encoding operon
in non-STEC pathotypes and determine whether it is phage asso-
ciated.
The aim of this study was to characterize the P2-like phage
sequence context flanking the cdt-Voperon in strainT22, anE. coli
O157:H43 strain of atypical pathotype (eae and stx negative), and
to monitor the presence of characteristic regions in other patho-
genic and nonpathogenic CDT-V-positive strains and in addi-
tional K-12 E. coli strains.
MATERIALS AND METHODS
Bacterial strains. Strains used in this study are listed in Table 1. Strains
were grown on lysogeny broth (LB) agar plates or bromothymol blue agar
plates.
Cosmid clone library construction and screening. Genomic DNA
was isolated from strain T22 of E. coliO157:H43 with the Sigma genomic
DNA kit (Sigma-Aldrich, St. Louis, MO). The preparation of the cosmid
clone library was performed with the pWEB-TNC cosmid cloning kit
(Epicentre, Madison, WI) according to the manufacturer’s instructions,
with the modification that genomic DNAwas subjected to a partial diges-
tion with restriction endonucleaseMboI (Fermentas, Vilnius, Lithuania).
All together, 1,000 transformant colonies were identified (cosmid library)
and screened for the presence of cdt-V using the primers indicated in
Table 2.
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Sequencing. Cosmid DNA was isolated by using the alkaline lysis
method (21), genomic DNA was isolated by using the GenElute bacterial
genomic DNA kit (Sigma-Aldrich, St. Louis, MO), and both were se-
quenced at the Biological ResearchCenter (Szeged,Hungary) by using the
Ion Torrent Personal Genome Machine (PGM) next-generation se-
quencer as well as traditional Sanger-based capillary sequencing. The av-
erage coverage for the prophage region was 112. Trimming and assem-
bly were performed manually and by using CLC Genomics Workbench
version 6.0.1. Nucleotide sequence analysis and searches for open reading
frames (ORFs) and homologous DNA sequences in the EMBL and Gen-
Bank database libraries were performed with the tools available from the
National Center for Biotechnology Information (www.ncbi.nlm.nih.gov)
together with Vector NTI and CLC Bio Genomics Workbench softwares.
PCR screening for flanking regions. E. coli strains representing dif-
ferent serotypes and pathotypes (Table 1) were tested by PCR for the
presence of characteristic P2-like phage genes. Primers were designed
with the aid of PrimerBLAST, available from the National Center for
Biotechnology Information. The general PCR conditions were an ini-
tial denaturation of 3 min at 94°C and then 30 cycles of denaturation
for 30 s at 94°C, followed by annealing for 30 s at 59 to 60°C (depend-
ing on the primer pair) and extension for 60 s at 72°C. The final
extension time was 5 min. The primers used in the reactions are listed
in Table 2.
Phage induction experiments. Phage induction was carried out for
the 8 strainsmarked inTable 1, using eithermitomycinC (0.5gml1) or
norfloxacin (1.25 g ml1) as inducing agents. Induction was also at-
tempted by UV irradiation as described by Hertman and Luria (22), with
themodification that doses were 15, 10, and 5 s long with a 30-W lamp. E.
coliK-12 strains ER2738, C600, and Shigella sonnei strain 866 (19), kindly
provided by Maite Muniesa, were used as indicator strains. As a positive
control for phage induction, the E. coli O157:H7 strain 34, harboring an
inducible Stx2 phage (23), was used.
Nucleotide sequence accession number. The nucleotide sequence of
the P2-like prophage has been deposited into GenBank (KC618326.1).
TABLE 2 Primers used for the investigation of P2-like regions
Primer name Target gene(s) Sequence 5= to 3= Position (bp)a Reference
FI_fw Tail sheath monomer FI gene TGCGTGTGGAAGACGGCACC 24612–24631 This study
FI_rev CGGCCTTGAGGGTTTCCGCAT 25413–25433 This study
Latecontrol_D_fw Late control protein D gene TTCGTGGCGCTGTCCTGACG 29694–29713 This study
Latecontrol_D_rev TGGAGAACTCCGCAACGCCC 30448–30467 This study
Terminase_fw Terminase gene GGGAGCCGAACGGATTGGCG 10561–10580 This study
Terminase_rev CTTGAGCACCGCATCCGCGA 11298–11317 This study
Capsid_fw Capsid gene CCGTCGGTCACCCAGACCCT 12975–12994 This study
Capsid_rev AGCGGCCAGCATTTCGCTGT 13655–13636 This study
Lysin_fw Lysin gene ATGCTGGCCGTGTCCGAAGG 15834–15853 This study
Lysin_rev CTGACCGTAACCGGCACCCG 16204–16223 This study
Tail_protein_fw Phage tail gene AGGGCGCTGACTGATGCCGT 17271–17290 This study
Tail_protein_rev AGCTCCATCGGGCGGGTGAC 17655–17674 This study
Baseplate_J_fw Baseplate gene J GGTTGCCCGTACCCTGACGC 19335–19354 This study
Baseplate_J_rev GACAGACGGATGTCGCGCCC 19960–19979 This study
L413C_specific_fw C (repressor) AGGATCCAGCCCTTTCTAAA 1632–1651 This study
L413C_specific_rev AATCCTTTTCGCGGAGTGG 1243–1261 This study
gpO_fw Capsid scaffolding protein O gene TTTCGTATCGGCGTTGAGG 11984–12002 This study
gpO_rev TGTTTTTCAGGCGGGTGAA 12710–12728 This study
cpxP2_fw cpxP integrase gene AGCCATATGTTCGACGGCAT 4327924–4327943* This study
integrase_rev AGGCCAGCGCCAAATTATTC 439–458 This study
P2_cdta_up_novel_fw Spacer region gene CCAAGAGCACGCCAGCACTGA 8727–8747 This study
P2_cdta_up_novel_rev TGGCAAATCTCCTTTGGGCTAGTG 8261–8284 This study
Cdta_up_novel_overlap_fw cdtA spacer gene TCAATCGCGTTTTGCACTCACGG 8500–8522 This study
Cdta_up_novel_overlap_rev AGGTCCAGCCCCGGGTAATGG 8018–8038 This study
P2_novel_overlap_fw Capsid packaging protein Q spacer gene ACAAGGGAAAGCCGACGGCAT 9259–9279 This study
P2_novel_overlap_rev TCAGTTATCGTCAGTGCTGGCGTGC 8717–8741 This study
Cdtc_P2_overlap_fw cdtC replication gene A CATACCTTCAACAACAGGTGCGGT 6227–6250 This study
Cdtc_P2_overlap_rev TACCGGTTCCCACGCCTTCTG 5591–5611 This study
P2_short_orfs_fw Short ORFs CGCCGTCAGGTTGGCGCAA 2367–2385 This study
P2_short_orfs_rev AACCAGCGCAGAAGCACCGC 3281–3300 This study
ogr_fw ogr-fieF ACGTGAATTGCAGCGCCACG 30840–30859 This study
fieF_rev CCAGCGCCAGCAGAATTGCG 4361610–4361629* This study
P2_PQ_fw Capsid packaging protein Q gene AACACCGCAACCTGCGGCAA 9974–9993 This study
P2_PQ_rev CCACCAGTAAACATCCTCT 9579–9597 This study
P2_P_fw Terminase protein P gene AACCTGTTCATGTGTGAA 10676–10693 This study
P2_P_rev AACGAGCTGGTGATGTCGG 10191–10209 This study
P2_repA_fw Replication gene A TTTCGATAATCTGGTTACG 4915–4933 This study
P2_repA_rev TATGGTCATGTTGCTGGCGC 4213–4232 This study
P2_repA_ext_fw Replication gene A distant region TTGCTTCAAAGACTGACTG 3376–3394 This study
P2_repA_ext_rev GAAATGAACGACGTCGAACGT 2298–2318 This study
CDT-IIIs cdt-VB GAAAGTAAATGGAATATAAATGTCCG 7291–7316 11
CDT-IIIas TTTGTGTCGGTGCAGCAGGGAAAA 6761–6784 11
a The reference sequence for the primers indicated with an asterisk is CP002967 (whole genome of Escherichia coli strain W). Positions are given in reference to GenBank accession
number KC618326.1, except where indicated otherwise.
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RESULTS
Characteristics of the P2-like prophage carrying the cdt-V clus-
ter. In order to determine the sequence of the cdt-V operon and its
exact position in the genome of E. coli O157:H43 strain T22, a
clone of the cosmid library positive for cdt-V, as well as the corre-
sponding region of the genomic DNA, was sequenced, annotated,
and deposited into GenBank. The length of the prophage contain-
ing the cdt-V operon is 31.2 kb. The cdt-V operon of strain T22
shows the highest nucleic acid similarity to the cdt operon of strain
AH-10 (GenBank no. AB472839). The sequence of cdtB, coding
for the active toxin subunit, is highly homologous to the AH-10-
specific sequence, with only 4 synonymous single-nucleotide
polymorphisms (SNPs). The CDT-V-encoding operon in strain
T22 is flanked by P2-like prophage sequences. The majority of
P2-like genes carried by T22 have the highest similarity to the
bacteriophage L-413C (97% similarity on average at the nucleo-
tide level; GenBank no. AY251033). The GC content of the cdt-V
operon is 41%, whereas the prophage genes exhibit an average GC
content of 53%. The structural organization of the P2-like phage
genes is reminiscent of the P2-like prophage in E. coli strain W
(GenBank no. CP002967). DNA sequence comparison between
the P2-like sequences of strains T22 andW revealed that there is a
high degree of nucleotide homology (94 to 99% identity) between
their genes (Table 3). The tail fiber-encoding genes (ORFs 33 to
36) located in the region ranging from bp positions 20720 to
23571 are different from all published P2-like prophages. The re-
spective phage tail fiber genes of the prophage in the genome of E.
coli strain UMNK88 (accession no. CP002729; with the homo-
logue of ORF 34 being present in two copies) are their closest
homologues, with a nucleotide identity of 92 to 99%. The region
between bp positions 22000 and 22192 is entirely missing in all
other P2-like prophage sequences available inGenBank, whereas it is
present in the prophage of UMNK88. The ORFs predicted in the
P2-like prophage of E. coliO157 strain T22 are listed in Table 3.
PCR scanning of P2-like genes. The dissemination of charac-
teristic cdt-V-flanking genes (n  20) in a collection of CDT-
producing and nonproducing strains was examined by PCR. At
least one gene from each P2-like functional gene cluster was in-
vestigated. The list of results, together with the genotype of the
strains, is given in Table 1. Fifteen out of 20 primer pairs designed
specifically for the flanking regions (Table 2) yielded PCR prod-
ucts in all CDT-V-positive strains. The overlapping primer pairs
covering the Q capsid gene and the spacer region between the Q
gene and cdtA yielded only a PCRproduct in theO157:H43 strains
tested, and the tail sheath monomer-encoding FI gene could be
amplified only from strain T22 and the O157:NMCDT-V strains.
Strains carrying different cdt types and the CDT-negative strains
carried fewer P2-like genes. Interestingly, the CDT-negative atyp-
ical strain B47 and the CDT-IV-positive strain 28C were positive
for 15 and 12 of the investigated sequences, respectively. Sequenc-
ing of the amplicons produced by the P2_PQprimer pair (Table 2)
showed that in this 376-bp region of the Q capsid gene, there was
amaximumof 14 SNPs, with only 3 of them leading to amino acid
changes.
Phage induction experiments from CDT-V-positive strains.
In order to induce lysogenic bacteriophages and to isolate corre-
sponding phage particles from the CDT-V-positive strains, phage
induction experiments were carried out with 8 CDT-V-positive
strains, marked in Table 1, by using UV light as well as mitomycin
C and norfloxacin as inducing agents. Among CDT-V-positive
strains, only EHEC O157:NM strains 702/88 and 493/89 released
phages upon induction with mitomycin C, which were able to
infect and lyse E. coli strain C600. PCR investigations revealed that
none of these phages carried cdt-V genes (data not shown). These
data indicate that the P2-like prophages harboring the cdt-V
operon cannot be induced from these stx-negative and cdt-V-pos-
itive E. coli O157 strains.
DISCUSSION
We sequenced for the first time awhole P2-like prophage from the
genome of E. coliO157:H43 strain T22 containing a cdt-V operon.
The cdt-V sequence in strain T22 is highly similar to that of the
cdt-V operon in strain AH-10 (16). Our results confirm and ex-
pand our knowledge based on previous reports that the cdt-V
operon is flanked by P2-like phage sequences (12, 16) and on a
more recent finding of an inducible P2-like phage carrying the
cdt-V operon (19). The proximal P2-like regions in E. coli T22 are
highly similar to the sequences published by the above-mentioned
authors; however, in our study, the entire prophage genome was
resolved and annotated. Among the lytic P2-like bacteriophages,
phage L-413C (induced originally from a Yersinia pestis strain [24,
25]) has the highest homology compared to the prophage se-
quence of strain T22 (GenBank no. AY251033). Among other
available prophage sequences, the P2-like prophage of E. coli
O157:H7 strain TW14359 (GenBank no. CP001368.1) is the clos-
est homologue. Compared to all the P2-like prophage sequences
available in GenBank, the level of homology between the individ-
ual structure genes and their closest homologues is between 94
and 100% (Table 3). The Z/fun region in the original P2 phage,
situated between the tail fiber geneG and the tail sheath gene FI, is
known to host insertions of foreign genes (26). In the case of strain
T22, the P2-like prophage does not contain a gene homologous to
theG gene. Instead, the tail fiber genes between bppositions 20720
and 23571 (ORFs 33 to 36; see Table 3) seem to have a different
origin in this strain, as they show only partial homology to P2-like
phages or prophages, their closest homologues being tail fiber
genes of a prophage carried by E. coli strain UMNK88. Among the
flanking ORFs, ORF 32 corresponds to gene H (upstream of G)
and ORF 37 to gene FI; therefore, the insertion of ORFs 33 to 36
occurred essentially in the Z/fun region, with the additional dele-
tion of gene G. Nilsson and coworkers suggested site-specific re-
combination as a possible mechanism for the insertion of foreign
genes in this region (27). The potential recombination of pro-
phages in E. coli O157 was already reported (28), and it was also
suggested that the mosaic structure of prophages is the result of
extensive exchange of genetic material among different bacterio-
phages and also their hosts (13), like in the case of lambdoid pro-
phages harboring the cdt-I and cdt-IV operons (13, 14). The ge-
nome sequencing project of strain T22 (29) confirmed that the
integration site of the prophage is between the cpxP and fieF genes.
This is the same site where P2-like prophages can be found in a
further fourE. coli strains according to publicly availableGenBank
entries (accession no. CP002967.1, CP002797.2, CP001969.1, and
CP000970.1).
The integration site of the cdt-V operon within the prophage,
the TO region, is known to be an integration hot spot for foreign
genes in P2-like phages (26). This region is named after the phage
immunity genes tin and old, encoded by the lytic phages in this
region. It has been suggested that this site is a potential carrier of
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advantageous genes for the host (26). The carriage of a potent
virulence-associated gene, like cdt-V, provides evidence for this
notion. It also has to be mentioned that, so far, CDT-V is the only
established virulence factor with its genes inserted into the TO
region of P2-like prophages. In complete P2-like prophage se-
quences available in GenBank, the TO region is usually occupied
by a gene coding for a hypothetical protein, or in the case of EHEC
O157:H7 strain TW14359, the genes of a putative virulence factor,
one of which shows partial homology to a eukaryotic serine es-
terase and a gene of Bacillus amyloliquefaciens (30). Genes encod-
ing reverse transcriptases have been also reported in the TO re-
gions of P2-like prophages found in the genomes of ECOR strains
(31). The foreign origin of the cdt-V operon is also supported by
the considerable difference between the GC content of the operon
and the prophage (41% versus 53%).
The fact that no phages were detected from any of the induced
TABLE 3 Functional annotation of the P2-like prophage in E. coli O157:H43 strain T22a
ORF Feature or product of sequence
Position
Size (bp)
No. of identical
nt/total no. of
nt, % identity
Reference accession
no. StrainStart End
1 Integrase 187 1167 981 980/981, 99 CP002797.2 NA114
2 Immunity repressor 1237 1530 294 294/294, 100 AY251033.1 Bacteriophage L-413C
3 Repressor, prophage excision 1667 1939 273 273/273, 100 CP002797.2 NA114
4 Unknown 1915 2112 198 196/198, 99 CP002797.2 NA114
5 DNA replication 2109 2609 501 501/501, 100 CP001368.2 TW14359
6 Unknown 2673 2897 225 223/225, 100 CP000800.1 E24377A
7 Unknown 2897 3199 303 290/303, 96 CP002967.1 W
8 Hypothetical zinc finger protein 3199 3423 225 221/225, 98 CP002185 W
9 Unknown 3420 3695 276 274/276, 99 CP002967.1 W
10 DNA replication 3685 5982 2,298 2191/2262, 97 CP002185 W
11 Cytolethal distending toxin C subunit 6058 6603 546 545/546, 99 AB472839 AH-10
12 Cytolethal distending toxin B subunit 6618 7427 810 809/810, 99 AB472860 AH-16
13 Cytolethal distending toxin A subunit 7424 8200 777 777/777, 100 JF461073 Bacteriophage fi125
14 Hypothetical protein 8779 8940 162 161/162, 99 AB472870 AH-26
15 Phage-related capsid packaging protein 8979 10013 1,035 1009/1035, 97 CP000970 SMS-3-5
16 Phage terminase, ATPase subunit 10014 11786 1,773 1724/1774, 97 AY251033.1 Bacteriophage L-413C
17 Phage capsid scaffolding protein 11894 12814 921 896/921, 97 CP002185 W
18 Phage major capsid protein 12873 13946 1,074 1060/1074, 97 CP002185 W
19 Phage terminase, endonuclease subunit 13951 14693 744 727/744, 98 AJ298566.1 Bacteriophage 299
20 Phage head completion, stabilization 14793 15302 510 499/510, 98 CP000970 SMS-3-5
21 Phage tail completion protein 15302 15505 204 202/204, 99 AY251033.1 Bacteriophage L-413C
22 Phage holin 15544 15789 246 246/246, 100 AY251033.1 Bacteriophage L-413C
23 Phage lysin 15789 16286 498 492/498, 99 CP002967.1 W
24 Phage holin, endolysin 16301 16726 414 420/426, 99 CU928161 S88
25 Phage spanin, Rz 16714 17139 426 412/426, 97 CP000970 SMS-3-5
26 Phage outer membrane lipoprotein 17126 17284 159 157/159, 99 CP002967.1 W
27 Phage tail protein 17247 17714 468 461/468, 99 CP002967.1 W
28 Phage tail completion protein 17707 18159 453 441/453, 97 CP002967 W
29 Baseplate assembly 18226 18861 636 622/636, 98 CP002967.1 W
30 Baseplate assembly 18858 19205 348 342/348, 98 CU928162 ED1a
31 Baseplate assembly 19210 20118 909 890/909, 98 CP001969 IHE3034
32 Phage tail fiber 20111 20722 612 603/612, 99 CP001368 TW14359
33 Phage tail fiber 20719 22218 1,500 1437/1502, 96 CP002729 UMNK88
34 Putative tail fiber assembly protein 22218 22820 603 595/603, 99 CP002729 UMNK88
35 Tail fiber assembly protein 22792 23235 444 433/444, 98 CP001368 TW14359
36 Hypothetical protein 23256 23570 315 289/315, 92 CP002729 UMNK88
37 Phage DNA invertase 23713 24207 495 468/499, 94 CP002967 W
38 Phage tail sheath protein 24362 25552 1,191 1173/1191, 98 HE616528 Shigella sonnei 53G
39 Phage tail tube protein 25565 26083 519 518/519, 99 CU928161 S88
40 Tail protein 26140 26415 276 267/276, 97 CP002516 KO11
41 Putative phage tail protein 26412 26567 156 156/156, 100 CP004009 APEC O78
42 Phage protein 26560 29007 2,448 2390/2448, 98 CU928162 ED1a
43 gpU (tail protein) 29022 29501 480 471/480, 98 CP002967 W
44 Gene D protein 29501 30664 1,164 1137/1164, 98 CU928161 S88
45 Putative positive regulator of lysis 30671 30964 294 288/294, 98 CP000970 SMS-3-5
a Positions refer to GenBank accession number KC618326.1. Homologies of 100% are in bold.
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cdt-V-positive strains, neither by induction with UV light, mito-
mycin C, or norfloxacin, is in harmony with current knowledge
that P2-like phages are classified as noninducible in E. coli (26).
This finding also suggests that the inducible prophages found in
STEC strains (19) may represent an earlier evolutionary stage of
the cdt-V-carrying P2-like prophages inE. coli and that the phages,
which we were unable to induce, could have become temperated
by adapting to the host organism.
The P2-like prophage sequences seem to be characteristic for
the CDT-V-positive strains, with few differences that can be at-
tributed to the adaptation processes in the various hosts. The pres-
ence of the L-413C-like C gene in the stx- and eae-negative O157
CDT-V strains, relative to EHECCDT-V strains, can be explained
with the high variability of this gene, which therefore can be used
as a marker to identify and distinguish different P2-like phage
variants (26). Our results suggest that while the stx-negative cdt-V
O157:H43 strains uniformly contain a P2-like variant with an
L-413C-likeC gene, the P2-like prophages in the other strainsmay
carry different variants of this gene, as they represent other evolu-
tionary lineages of P2-like phages. It will be an important future
task to evaluate whether different P2-like bacteriophage variants
may be associatedwith individualE. coli clonal groups and/orwith
different virulence factors in their TO region. An interesting find-
ing was the carriage of P2-like genes by strain 28C, an extraintes-
tinal pathogenic E. coli strain, which harbors the cdt-IV operon
flanked by lambda phage-like genes (14). This observation may
indicate that the P2-like genes could be located elsewhere in the E.
coli 28C genome. Alternatively, recombination between a P2-like
and a lambdoid phage cannot be excluded. Another example of
P2-like phages serving as vehicles for foreign DNA can apparently
be found in the CDT-negative atypical O157:NM strain B47,
which also carries most of the P2-like prophage genes investigated
and is where the integration site between cpxP and fieF also seems
to be occupied. Strain B47 probably also carries a nearly complete
P2-like prophage similar to other investigated O157 CDT-V
strains, with as-yet-unknown genes inserted into its integration
hot spots. On the other hand, the PCRs specific for the integration
site of the P2-like prophage were negative in the case of the
O157:NMEHEC strains, suggesting a different integration site for
the prophage in these isolates. The atypicalO157 strains harboring
P2-like genes are phylogenetically distinct from those that do not
carry them. While the CDT-negative O157 strains (T4, B20, and
B54; all representing the O157:H12 serotype) belong to phyloge-
netic group A, the CDT-positive O157 strains (T22, T16, T34,
T49, T50), as well as strain B47, belong to phylogenetic group B1
(Table 1) (32).
It has been proposed that the presence of P2-like phage se-
quences suggests the common acquisition of the cdt-V operon in
O157:NM EHEC strains after the lineage has diverged from the
O157:H7 strains (12). While there is indeed a strong association
between O157:NM strains and the presence of CDT-V (17, 19,
33), several strains from other serotypes, both from healthy cattle
(23, 33) and from cases of human diarrhea (15, 16, 17, 34), express
CDT-V. These findings, together with the results of our study,
indicate thatwhile the cdt-V genes are rather conserved, the carrier
P2-like phages became diverse during the evolution of their hosts,
and this event in most cases may have resulted in loss of their
mobility. These facts suggest a more diverse evolutionary and/or
transductional history of the cdt-V operon and its carrying of P2-
like prophages. The highly conserved cdt-V operon within more
variable and potentially inactivated bacteriophage genomes may
result from selective pressure to maintain a functional cdt gene
cluster and to stabilize this cargo determinant by inactivation of
this bacteriophage genome. Further investigations of flanking re-
gions and P2-like prophage sequences in CDT-V-positive strains
are expected to help in clarifying the evolutionary background of
the distribution of these variants.
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